Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longchuan Bai

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
ACS Medicinal Chemistry Letters|December 21, 2016
Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D InhibitorsChao-Yie Yang, James G Phillips, Jeanne A Stuckey, et al.
Journal of Medicinal Chemistry|November 18, 2008
Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspasesBin Zhang, Zaneta Nikolovska-Coleska, Yan Zhang, et al.
The Journal of Biological Chemistry|September 18, 2007
Reduced pepsin A processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformationYana Zavros, Meghna Waghray, Arthur Tessier, et al.
Journal of Medicinal Chemistry|March 2, 2013
A potent and highly efficacious Bcl-2/Bcl-xL inhibitorAngelo Aguilar, Haibin Zhou, Jianfang Chen, et al.
Plos One|March 23, 2013
Gli1 deletion prevents Helicobacter-induced gastric metaplasia and expansion of myeloid cell subsetsMohamad El-Zaatari, John Y Kao, Art Tessier, et al.
Accounts of Chemical Research|October 22, 2008
Design of small-molecule peptidic and nonpeptidic Smac mimeticsHaiying Sun, Zaneta Nikolovska-Coleska, Chao-Yie Yang, et al.
Journal of Medicinal Chemistry|June 17, 2015
Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain InhibitorsXu Ran, Yujun Zhao, Liu Liu, et al.
Journal of Medicinal Chemistry|October 4, 2012
Structure-based discovery of BM-957 as a potent small-molecule inhibitor of Bcl-2 and Bcl-xL capable of achieving complete tumor regressionJianfang Chen, Haibin Zhou, Angelo Aguilar, et al.
Journal of Medicinal Chemistry|July 5, 2026
Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single AdministrationRanjan Kumar Acharyya, Longchuan Bai, Haibin Zhou, et al.
Journal of Medicinal Chemistry|July 4, 2012
Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activityHaibin Zhou, Angelo Aguilar, Jianfang Chen, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
ACS Medicinal Chemistry Letters|December 21, 2016
Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D InhibitorsChao-Yie Yang, James G Phillips, Jeanne A Stuckey, et al.
Journal of Medicinal Chemistry|November 18, 2008
Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspasesBin Zhang, Zaneta Nikolovska-Coleska, Yan Zhang, et al.
The Journal of Biological Chemistry|September 18, 2007
Reduced pepsin A processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformationYana Zavros, Meghna Waghray, Arthur Tessier, et al.
Journal of Medicinal Chemistry|March 2, 2013
A potent and highly efficacious Bcl-2/Bcl-xL inhibitorAngelo Aguilar, Haibin Zhou, Jianfang Chen, et al.
Plos One|March 23, 2013
Gli1 deletion prevents Helicobacter-induced gastric metaplasia and expansion of myeloid cell subsetsMohamad El-Zaatari, John Y Kao, Art Tessier, et al.
Accounts of Chemical Research|October 22, 2008
Design of small-molecule peptidic and nonpeptidic Smac mimeticsHaiying Sun, Zaneta Nikolovska-Coleska, Chao-Yie Yang, et al.
Journal of Medicinal Chemistry|June 17, 2015
Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain InhibitorsXu Ran, Yujun Zhao, Liu Liu, et al.
Journal of Medicinal Chemistry|October 4, 2012
Structure-based discovery of BM-957 as a potent small-molecule inhibitor of Bcl-2 and Bcl-xL capable of achieving complete tumor regressionJianfang Chen, Haibin Zhou, Angelo Aguilar, et al.
Journal of Medicinal Chemistry|July 5, 2026
Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single AdministrationRanjan Kumar Acharyya, Longchuan Bai, Haibin Zhou, et al.
Journal of Medicinal Chemistry|July 4, 2012
Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activityHaibin Zhou, Angelo Aguilar, Jianfang Chen, et al.
Pageof 7